Kommentar
Risk Stratification in Steatotic Liver Disease
JAMA Internal Medicine · 01.11.2026 · 186 (11) · 1367
DOI: 10.1001/jamainternmed.2026.4120 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.11.2026. Verfasst von Melinda Wang. Beteiligte Einrichtung: Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco.
Zitieren
APA
Wang, M. (2026). Risk Stratification in Steatotic Liver Disease. JAMA Internal Medicine, 186(11), 1367. https://doi.org/10.1001/jamainternmed.2026.4120
Vancouver
Wang M. Risk Stratification in Steatotic Liver Disease. JAMA Internal Medicine. 2026;186(11):1367. doi:10.1001/jamainternmed.2026.4120
BibTeX
@article{Wang2026,
author = {Wang, Melinda},
title = {Risk Stratification in Steatotic Liver Disease},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {11},
pages = {1367},
doi = {10.1001/jamainternmed.2026.4120}
}
EUVIMED